Healthcare Stock Gainers: BG Medicine, Optimer Pharmaceuticals, Merck & Co, Questcor Pharmaceuticals

Lakeway, TX -- (SBWIRE) -- 02/27/2013 -- Bestdamnpennystocks, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the following stocks:-

BG Medicine, Inc.(NASDAQ:BGMD) is higher 8.94% and is trading at $1.95. BG Medicine, Inc. (BG Medicine) is a life sciences company focused on the discovery, development and commercialization of cardiovascular diagnostics to addresses unmet medical needs. The Company focuses on blood-based tests. Its lead product candidate in development is CardioSCORE, which is a multi-analyte biomarker-based blood test for atherothrombotic cardiovascular disease, commonly known as vulnerable plaque.

How Should Investors Trade BGMD After The Recent Movement? Find Out Here

Optimer Pharmaceuticals, Inc.(NASDAQ:OPTR) jumped 13.29% and is trading at $12.15. Optimer Pharmaceuticals, Inc. (Optimer) is a biopharmaceutical company focused on developing and commercializing hospital specialty products. The Company’s development is focused on products that treat gastrointestinal infections and related diseases.

Is OPTR Strong Buy After The Recent Strong Gains? Get Free Trend Analysis Here

Merck & Co., Inc.(NYSE:MRK) is higher 0.64% and is trading at $42.69. Merck & Co., Inc. (Merck) is a global health care company that delivers health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products, which it markets directly and through its joint ventures. The Company’s operations are principally managed on a products basis and consists of four segments: the Pharmaceutical, Animal Health, Consumer Care and Alliances segments, and one reportable segment: the Pharmaceutical segment.

Is MRK a Buying Opportunity After The Recent Plunge? Don’t Miss Out Our Latest Report Here

Questcor Pharmaceuticals, Inc.(NASDAQ:QCOR) added 3.58% and is trading at $33.83. Questcor Pharmaceuticals, Inc. (Questcor) is a biopharmaceutical company. The Company’s primary product is H.P. Acthar Gel (repository corticotropin injection) (Acthar), an injectable drug that is approved by the United States Food and Drug Administration, for the treatment of 19 indications.

How Should Investors Trade QCOR After The Latest Earnings Report? Find Out Here

About bestdamnpennystocks.com

Best Damn Penny Stocks’ team is engaged in providing stock newsletters on various hot penny stocks on a regular basis. Our instant stock news on Major Gainers, small cap penny stocks and various other stocks, guides investors in making the wise stock market investments decision. In order to get update to the markets, we would advise you sign up to our free newsletters. You can become leader in stock market by keeping track of the daily activity.

Disclaimer
The assembled information disseminated by Bestdamnpennystocks.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Bestdamnpennystocks.com does expect that investors will buy and sell securities based on information assembled and presented in Bestdamnpennystocks.com. PLEASE always do your own due diligence, and consult your financial advisor.